Article Text

Download PDFPDF
Renal impairment following aminoglycoside therapy in cystic fibrosis
  1. A Tai
  1. Dr A Tai, Department of Respiratory Medicine, Royal Children’s Hospital Melbourne, Victoria 3052, Australia; andrew.tai{at}rch.org.au

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Cystic fibrosis (CF) is a chronic respiratory, life limiting illness in the Caucasian population. Chronic infection with Pseudomonas aeruginosa occurs in more than 80% of adults and this contributes to deterioration in lung function over time.1 A reported long term complication includes renal impairment from presumed cumulative aminoglycoside antibiotics. Aminoglycosides are highly effective against Pseudomonas aeruginosa and effectively penetrate the sputum of patients with CF, achieving more effective bacterial killing.2 The nephrotoxicity of aminoglycosides is reported to …

View Full Text

Footnotes

  • Competing interests: None.

Linked Articles

  • Letters
    A Smyth C Bertenshaw S Lewis I Choonara A Watson